Cite

Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding.

MLA

Gagnon, Yves M., et al. “Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding.” Value in Health, vol. 6, no. 4, July 2003, pp. 457–65. EBSCOhost, https://doi.org/10.1046/j.1524-4733.2003.64262.x.



APA

Gagnon, Y. M., Levy, A. R., Eloubeidi, M. A., Arguedas, M. R., Rioux, K. P., & Enns, R. A. (2003). Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding. Value in Health, 6(4), 457–465. https://doi.org/10.1046/j.1524-4733.2003.64262.x



Chicago

Gagnon, Yves M., Adrian R. Levy, Mohamad A. Eloubeidi, Miguel R. Arguedas, Kevin P. Rioux, and Robert A. Enns. 2003. “Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding.” Value in Health 6 (4): 457–65. doi:10.1046/j.1524-4733.2003.64262.x.